Prior treatment characteristics
| . | Total (N = 50) . |
|---|---|
| Number of prior regimens | |
| 1 | 14 (28) |
| 2 | 14 (28) |
| 3 | 12 (24) |
| 4 | 9 (18) |
| 5 | 1 (2) |
| Refractory to immediate prior therapy | |
| Yes | 13 (26) |
| Prior regimens | |
| IMiD | |
| Thalidomide | 10 (20) |
| Lenalidomide | 50 (100) |
| Proteasome inhibitors | |
| Bortezomib | 29 (58) |
| Other proteasome inhibitors | 17 (34) |
| Corticosteroids | 48 (96) |
| Alkylators | 28 (56) |
| Antimetabolites | 2 (4) |
| Vinca alkaloids | 1 (2) |
| Other | 4 (8) |
| Prior transplant | 36 (72) |
| Lenalidomide refractory | 50 (100) |
| . | Total (N = 50) . |
|---|---|
| Number of prior regimens | |
| 1 | 14 (28) |
| 2 | 14 (28) |
| 3 | 12 (24) |
| 4 | 9 (18) |
| 5 | 1 (2) |
| Refractory to immediate prior therapy | |
| Yes | 13 (26) |
| Prior regimens | |
| IMiD | |
| Thalidomide | 10 (20) |
| Lenalidomide | 50 (100) |
| Proteasome inhibitors | |
| Bortezomib | 29 (58) |
| Other proteasome inhibitors | 17 (34) |
| Corticosteroids | 48 (96) |
| Alkylators | 28 (56) |
| Antimetabolites | 2 (4) |
| Vinca alkaloids | 1 (2) |
| Other | 4 (8) |
| Prior transplant | 36 (72) |
| Lenalidomide refractory | 50 (100) |
Values are reported as n (%) of patients.